Editorial comment on: "The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced non-small cell lung cancer receiving palliative chemotherapy". by Vincent et al.

Suppr

超能文献

作者信息

Korte Wolfgang

出版信息

Support Care Cancer. 2007 Mar;15(3):239-41. doi: 10.1007/s00520-006-0188-5. Epub 2006 Dec 6.

DOI:10.1007/s00520-006-0188-5

PMID:17149629

Abstract

摘要

相似文献

Editorial comment on: "The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced non-small cell lung cancer receiving palliative chemotherapy". by Vincent et al.

Support Care Cancer. 2007 Mar;15(3):239-41. doi: 10.1007/s00520-006-0188-5. Epub 2006 Dec 6.

The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced nonsmall cell lung cancer receiving palliative chemotherapy.

Support Care Cancer. 2007 Mar;15(3):265-72. doi: 10.1007/s00520-006-0154-2. Epub 2006 Nov 21.

Reply to P. Baldo et al.

J Clin Oncol. 2015 Sep 1;33(25):2826. doi: 10.1200/JCO.2015.62.5699. Epub 2015 Jul 20.

Palliative chemotherapy for advanced non-small cell lung cancer.

BMJ. 1994 Feb 12;308(6926):429-30. doi: 10.1136/bmj.308.6926.429.

Palliative chemotherapy for non-small cell lung cancer: a measured dose of reality.

J Support Oncol. 2007 Jan;5(1):27-8.

Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: the JBR.10 trial experience.

Lung Cancer. 2007 Mar;55(3):357-63. doi: 10.1016/j.lungcan.2006.10.021. Epub 2006 Dec 1.

Palliative benefits of chemotherapy treatment in non-small cell lung cancer may be underappreciated.

J Support Oncol. 2006 Feb;4(2):61.

Side-effects of cancer drugs are under-reported in trials.

Lancet Oncol. 2015 Mar;16(3):e107. doi: 10.1016/S1470-2045(15)70023-9. Epub 2015 Jan 30.

Doctors less likely than patients to report toxicity of cancer treatments, study shows.

BMJ. 2015 Jan 27;350:h485. doi: 10.1136/bmj.h485.

[The role of adjuvant chemotherapy in non-small-cell lung cancer. Against].

Suppl Tumori. 2004 Jul-Aug;3(4):S45-7.

本文引用的文献

The use of erythropoietin in patients undergoing radical prostatectomy: effects on hematocrit, transfusion rates and quality of life.

Urol Int. 2006;77(3):211-5. doi: 10.1159/000094811.

Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy.

J Clin Oncol. 2006 Aug 1;24(22):3583-9. doi: 10.1200/JCO.2005.03.4371.

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.

J Natl Cancer Inst. 2006 May 17;98(10):708-14. doi: 10.1093/jnci/djj189.

Cancer patient survival and erythropoietin.

J Natl Compr Canc Netw. 2005 Nov;3(6):796-804. doi: 10.6004/jnccn.2005.0048.

The ASH/ASCO clinical guidelines on the use of erythropoietin.

Best Pract Res Clin Haematol. 2005;18(3):433-8. doi: 10.1016/j.beha.2005.01.020.

The blue cross blue shield assessment technology review: summary of findings.

Best Pract Res Clin Haematol. 2005;18(3):423-31. doi: 10.1016/j.beha.2005.01.019.

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.

Eur J Cancer. 2004 Oct;40(15):2201-16. doi: 10.1016/j.ejca.2004.07.015.

Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.

J Clin Oncol. 2005 Apr 20;23(12):2606-17. doi: 10.1200/JCO.2004.10.020. Epub 2004 Sep 27.

[Standards, options and recommendations for the use of recombinant erythropoietin (epoietin alpha and beta darbepoietin-alpha, EPO) in the management of anaemia in oncology for patient undergoing radiotherapy-update 2003].

Cancer Radiother. 2004 Jun;8(3):197-206. doi: 10.1016/j.canrad.2004.04.001.

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.

Lancet. 2003 Oct 18;362(9392):1255-60. doi: 10.1016/S0140-6736(03)14567-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验